GUO Weiqin's experience in differentiation and treatment of doxorubicin-induced cardiac dysfunction with Yiqi Xiefei Decoction based on the theory of "cardiopulmonary co-treatment"
LI Meng,SUN Rui,NIU Chaofeng,et al.GUO Weiqin's experience in differentiation and treatment of doxorubicin-induced cardiac dysfunction with Yiqi Xiefei Decoction based on the theory of "cardiopulmonary co-treatment"[J]. Beijing Journal of Traditional Chinese Medicine,2025,44(08):1023-1025.
LI Meng,SUN Rui,NIU Chaofeng,et al.GUO Weiqin's experience in differentiation and treatment of doxorubicin-induced cardiac dysfunction with Yiqi Xiefei Decoction based on the theory of "cardiopulmonary co-treatment"[J]. Beijing Journal of Traditional Chinese Medicine,2025,44(08):1023-1025. DOI: 10.16025/j.1674-1307.2025.08.015.
Heart disease has become the leading cause of non-cancer-related death among cancer patients. Doxorubicin-induced heart failure is a key issue in cardio-oncology. Traditional Chinese medicine has unique advantages in preventing and treating doxorubicin-induced heart failure. Deficiency, blood stasis, and toxicity are the pathological basis of doxorubicin-induced cardiotoxicity. The correlation between the heart and lungs, and the concept of "cardiopulmonary co-treatment", are key to both the pathogenesis and treatment of doxorubicin-induced heart failure.
Yiqi Xiefei
Decoction
is one of the representa
tive formulas for cardiopulmonary co-treatment and has significant advantages in treating doxorubicin-induced heart failure.
关键词
Keywords
references
RIVIER C , MERY B , ROWINSKI E , et al . Breast cancer treatment-related cardiovascular disturbances: advocacy for a watchful attitude in this never-ending story [J ] . Expert Opin Drug Saf , 2022 , 21 ( 4 ): 453 - 465 .